Revenue and Deferred Revenue

9 Months Ended

Sep. 30, 2025

Revenue Recognition and Deferred Revenue [Abstract]

Revenue and Deferred Revenue

5.REVENUE AND DEFERRED REVENUE

Product revenue consists of instruments with embedded software essential to the instrument's functionality and consumables. Service revenue primarily consists of revenue received from the generation and analysis of proteomic data on behalf of customers. Related party revenue is comprised of both the sale of products and services performed for related parties, as further discussed in Note 10. Other revenue consists of shipping revenue and lease arrangements.

Deferred revenue activities consist of the following (in thousands):

	Nine Months Ended September 30,
	2025			2024
Deferred revenue, current and noncurrent, as of the beginning of period	$	456		$	270
Additions		637			523
Revenue recognized		(597	)		(380	)
Deferred revenue, current and noncurrent, as of the end of period	$	496		$	413

The transaction price allocated to remaining performance obligations relates to amounts allocated to products, services and lease arrangements for which revenue has not yet been recognized. A significant portion of these performance obligations relate to service obligations that will be satisfied and recognized as revenue in future periods. As of September 30, 2025, the Company had $0.5 million of remaining performance obligations, of which 85% is expected to be recognized within twelve months.